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Honey is recognized traditionally for its medicinal properties and also appreciated as a topical healing agent for infected
and noninfected wounds. This study evaluates impact of honey-based occlusive dressing on nonhealing (nonresponding to
conventional antibiotics) traumatic lower limb wounds (n = 34) through clinicopathological and immunohistochemical
(e.g., expression of p63, E-cadherin, and Collagen I and III) evaluations to enrich the scientiﬁc validation. Clinical ﬁndings
noted the nonadherence of honey dressing with remarkable chemical debridement and healing progression within 11–15 days
of postintervention. Histopathologically, in comparison to preintervention biopsies, the postintervention tissues of wound
peripheries demonstrated gradual normalization of epithelial and connective tissue features with signiﬁcant changes in p63+
epithelial cell population, reappearance of membranous E-cadherin (P<. 0001), and optimum deposition of collagen I and III
(P<. 0001). Thus, the present study for the ﬁrst time reports the impact of honey on vital protein expressions in epithelial and
connective tissues during repair of nonhealing lower limb wounds.
1.Introduction
Wound healing involves complex and multifactorial biologi-
cal processes with overlapping stages [1]. However, in non-
healing wounds, successive repairing stages are aﬀected by
varied pathological happening including infection [2–4],
imbalance in extracellular matrix formation and degrada-
tion [5, 6], impaired re-epithelialization [7] and nutritional
supply, adverse microenvironment, and repeated physical
trauma [8]. So, healing interventions need to address these
pathological variables to facilitate cellular and molecular
events towards re-epithelialization, connective tissue forma-
tion, and maturation of regenerating tissues [9–11].
The re-epithelialization is orchestrated by keratinocyte
proliferation and migration which are again correlated with
expression of p63, a marker of undiﬀerentiated proliferating
cells [12] and development of stratiﬁed epithelial [13–15].
Therefore, the diﬀerential p63 expression in venous ulcers
and otherepidermalulcersincomparison tohealthy wounds
are no doubt indicative in understanding the impaired
healing [7, 16]. Nevertheless, membranous expression of
E-cadherin, a calcium-dependent cell-surface glycoprotein
responsible for cell-cell adhesion [17], is essential for estab-
lishing epithelial integrity [18, 19]. In the context of wound
re-epithelialization, the involvement ofE-cadherin especially
in controlling cellular polarity [20], diﬀerentiation, growth,
and migration [21] is crucial. Further, connective tissue
formation during repair and to prevent scarring, optimum
deposition of collagen I and III with their proper ratio is
important [22, 23]. In particular, collagen I is responsible
for higher tensile strength, whereas collagen III is pre-
dominantly found in early wound healing stages [9, 24,
25], and they maintain a particular ratio [26]i nh e a l t h y
skin. The geometrical arrangement of ﬁbrillar collagen and
their optimum ratio are vital during healing progression
to maintain required crosslinked density and mechanical
toughness [27, 28].
The lower extremity wound healing exhibits remarkable
complexity due to negative impact of various anatomical
and functional parameters as well as harsh eﬀect of gravity
on blood transportation. The taut foot skins are susceptible
for frequent ulceration, as their terminal capillary plexus2 Evidence-Based Complementary and Alternative Medicine
is exposed to various pressure gradients [29]. Evaluation
of above-mentioned molecules in terms of their expression
couldbevitalespeciallyinassessing theimpactofanyhealing
interventions.
Honey, being a natural nutritional reservoir contain-
ing various organic/inorganic substances including major
amounts of carbohydrates along with lipids, amino acids,
proteins, vitamin, bioelements [30, 31]w i t ha c i d i cp H( ∼4)
possesses multidimensional prohealing eﬀects for infect-
ed/noninfected wounds [32], ﬁnds application as a topical
agent with optimal moisture retention capacity, debride-
ment ability and anti-inﬂammatory eﬀect[33–35]. However,
deeper understanding is required for biological validation of
its impact especially on vital cellular and molecular events
relatedtoimportant repair processes likere-epithelialization,
subepithelialconnective tissue formation ofwounds toguide
clinicians.
With these facts in mind, present study evaluates healing
impactofhoneyasatopicalagentintreatment ofnonhealing
traumatic lower limb wound (LLW) through immunohisto-
chemical analysis of p63, E-cadherin, and collagen I and III
in addition to routine histopathologicaland clinicalobserva-
tions.
2.Materialsand Methods
2.1. Clinical Study. The patients (n = 34) of either gender
(age= 16–65years) withnonhealing lower extremity wounds
(traumatic origin) with exudation of pus, foul smell, and
necrotic tissues and nonresponding to conventional topical
antibiotics were included under informed written consent.
Ethical clearance was obtained from institutional ethical
committee according to Helsinki declaration. Subsequently,
physicochemically characterized honey- (ripe and dark
amber colored honey with ∼14% water content, ∼4p Ha n d
viscosity 4.16 Pas at 37◦C, collected from bee keepers of
greater Kolkata, India) based occlusive dressing (i.e., honey-
soaked gauge followed by a layer of dry cotton tied with
crepe elastic bandage) was applied on LLW. Redressing was
performed with an interval of 24hrs for initial 7-8 days
having foul odor, exudation, and necrotic tissues in the
wounds and with progression of healing interval increased
to 48–72 hours. Clinically, pain, malodor, oedema, debride-
ment, granulation tissue formation, and epithelialization
were recorded.
2.2. Histopathological and Immunohistochemical Studies.
Incisional biopsiesfromwound edgewere collected fromfew
cases(n = 21)underlocalanaesthesia (Xylocaine)beforeand
after (i.e., 15th and 22nd day) honey dressing. The normal
skin samples collected from superﬂuous tissues of surgical
interventions.
2.2.1. Tissue Processing. Biopsies ﬁxed with 10% phosphate
buﬀered formalin and processed for 4µmt h i c kp a r a ﬃn
sectionsonpoly-L-lysine (Cat.No.P8920Sigma-Aldrich,St.
Louis, MO, USA) coated slides.
2.2.2. Hematoxylin and Eosin (H and E) and Van Gieson’s
Staining (VG). Tissue sections stained withhematoxylinand
eosin as well as VG [36].
2.2.3. Immunohistochemistry. Tissue sections baked and
deparaﬃn i z e dt h e nh y d r a t e df o ra n t i g e nr e t r i e v a li n1 0m M
citrate buﬀer (pH 6.0) using EZ-Retriever System V.2 (Bio-
Genex, San Ramon, California, USA) and immunostained
with kit (i.e., Super Sensitive Polymer-HRP IHC Detection
System Cat. no: QD400-60K BioGenex). Sections incubated
with primary antibodies (antihuman p63 clone 4A4, Cat.
no. AM418-5M, and anti-Collagen III clone HWD1.1,
AM167-5M BioGenex; E-Cadherin, clone EP700Y, Cat. no.
ab40772, and anti-Collagen I polyclonal, ab34710, Abcam,
Cambridge, UK) p63 and Collagen III, whereas a dilution
of 1:500 was used for E-cadherin and Collagen I. Primary
antibody binding visualized using a horseradish peroxidase
conjugated secondary antibody using the chromogen 3, 3 -
diaminobenzidine (DAB) and counterstained with hema-
toxylin. Appropriate controls were put up to validate the
experiments.
2.3. Microscopic Studies. The histopathological and immun-
ohistochemical assessments were performed using Zeiss
Observer.Z1 Microscope (Carl Zeiss, Germany) under 20x
(NA 0.8; pixel resolution 0.31) and 40x oil (NA 1.3; pixel
resolution 0.16). The images were grabbed digitally by CCD
camera (AxioCam MRC, Zeiss) at 1388 × 1040 pixels.
2.4. Semiquantitative Evaluation of Immunohistochemical
Observations. In this study, from each study class, that is,
normal, pre- and postintervention (15th and 22nd days), 21
tissue sections were assessed. In this process, digital images
fromthe respective study classeswere selectedrandomly,and
following analysis was performed with the help of expert
histopathologists.
2.4.1. Counting of p63+ Cells. The p63+ epithelial cell popu-
lation per microscopic ﬁeld, throughout the epithelium, was
counted under 20x objectives.
2.4.2. Assessment of Intensity Variation for E-Cadherin, and
Collagen I and III Expressions. The expression intensities of
E-Cadherin was measured along the expression path as per
an intensity scoring scale (i.e., 0–10) at three equidistant
points that is, P1, P2, and P3 of the epithelium (Figure 1(a))
using the software Axiovision (Version 4.7.2, Carl Zeiss,
Germany). Further, to assess the cellular site speciﬁc E-
cadherin expression and its overall distribution in the
stratum basilaris and stratum spinosum in terms of color
intensity (Table 2), a 10-point intensity scoring scale was
used considering maximum membranous expression as“10”
and maximum cytoplasmic expression as “0”.
The intensity variations of the collagen I and III were
measured at three equidistant study points, that is, P1, P2,
and P3 (Figure 1(b)), within 200µm range below basement
membrane using above-mentioned intensity [37]s c o r i n g
scale. In this purpose, 30 random points were selectedEvidence-Based Complementary and Alternative Medicine 3
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Figure 1: Schematic representation of the adopted method to generate intensity data for E-cadherin (a) and Collagens I and III (b). In both
assessments,basement membrane (BM) was used as reference point. For E-cadherin (a), the P1, P2, and P3 along the white line represented
three equidistant points in the epithelial expression path, while expression of collagen molecules in dermis (b) were assessed along 200µm
(the white vertical line) below basement membrane at three equidistant points that is, P1, P2, P3.
from photomicrograph of each study groups under 20x
objective. Further, the ratio between Collagen I and III was
measured from mean values of their intensities. All these
semiquantative assessment were performed under guidance
of expert histopathologist.
2.5. Statistical Evaluation. Independent sample “t”-test was
applied for the analysis of p63 data. The E-cadherin and
collagen expression intensity scores at diﬀerent study points
that is, P1, P2, and P3 were analyzed using analysis of
variance (ANOVA).
3.Results
3.1. Healing of LLW under Topical Application of Honey
3.1.1. Clinical Observations on LLW. Clinically, the remark-
able decrease of pain, oedema, and malodor was noted
within 11–15 days of honey dressing. The granulation tissue
formation and re-epithelialization were observed within 7–
11and 12–15days,respectively, after intervention(Figure 2).
Interestingly, there was no need of mechanical debridement
of the necrotic tissues and nonadhesiveness of the dressing
was signiﬁcant in inhibiting further trauma to the wound
bed.
3.2. Histopathological Observations. The microscopic obser-
vations under H and E staining revealed that on 15th
and 22nd days after intervention, histological features were
improved remarkably with the appearance of rete pegs and
progressive maturation of the epithelial cells and connective
tissue components. The VG studies depicted improvement
in collagen population in respect to their density and
distributioninachieving therandomorientationlikenormal
skin.
3.3. Immunohistochemical Findings. In respect to p63+ cell
population, diﬀerences were demonstrated between normal
epithelium (Figure 3(a)) and wound bed margins before
(Figure 3(b)) and after (Figures and 3(c) and 3(d))h o n e y
dressing. In comparison to normal (p63+ ∼ 90%), positive
cell population was remarkably less (p63+ ∼ 78.3%) in pre-
dressing biopsies, but the values moved towards normalcy
on 15th (p63+ ∼ 80.4%) and 22nd (p63+ ∼ 86.8%) days of
postintervention.
In respect to E-cadherin expression (Figures 3(e)–3(h),
there was remarkable diﬀerence between pre- (Figure 3(f))
and postapplication (Figures 3(g),a n d3(h)) biopsies (Tables
1 and 2). In comparison to normal membranous expression
of E-cadherin, it was mostly cytoplasmic (Figure 3(e))a n d
less intense (P<. 0001) in epithelium of preintervention
biopsies. However, in postintervention biopsies, the mem-
branous expressions were signiﬁcantly increased (P<. 0001)
mostly above the basal layers like normal skin (Figures 3(g),
and 3(h)). Further, the assessment of E-cadherin expres-
sion in stratum basilaris and stratum spinosum depicted
remarkable diﬀerences amongst pre- and postintervention
biopsies and demonstrated the expression towards normalcy
in stratum basilaris stratum spinosum on 20th day of
postintervention (Table 2).
The collagen I and III expressions (Figures 3(i)–3(p))
in subepithelial connective tissue of preintervention biopsies
showed signiﬁcantly higher population density (P<. 0001)
withparallel orientation(Figures3(j),and3(n))whileindif -
ferent postapplication biopsies both collagen types became
less dense and distributed randomly (Figures 3(k), 3(l),a n d
3(o), 3(p)). Further, the ratio between collagen I and III
(Table 1) was signiﬁcantly high (1.57) in preintervention
samples which was decreased in postintervention periods
(i.e., 1.49 after 15 days and 1.31 after 22 days) towards the
ratio of normal skin (1.25).
4.Discussion
During tissue repair the reconstitution of the epithelial
barrierandconnectivetissuewithoptimumlevelsofcollagen
deposition is essential [38] and synchrony between the
processes is vital in preventing anomaly in wound repair
[39]. Hence, to understand topical impact of honey dressing
on nonhealing wounds, present work focused on the eval-
uation of the immunohistochemical analysis on molecular4 Evidence-Based Complementary and Alternative Medicine
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Figure 2: Representative photographs of lower limb wound showing healing under topical application of honey: (a) before application (b)
35 days, and (c) 180 days after application.
expressions related to re-epithelization and connective tissue
statustoovercomeinadequacyofroutine clinicopathological
gold standards.
The reductionofpain,edema,malodorand debridement
within reasonable time in LLW after such dressing as noted
in this study signiﬁes the anti-inﬂammatory, anti-bacterial
and chemical debridement ability of acidic, viscous and
hygroscopichoney [40–42]. These are corroborativewith the
previous ﬁndings that acidic pH of honey have inﬂuence on
cellular,molecularcascadesinwoundbedtoacceleraterepair
of nonhealing conditions [32]w h i c hs h o w st e n d e n c yo f
acquiringalkalinepH[43,44].The nonadherence ofdressing
and optimum granulation tissue formation further indicated
the prohealing eﬃcacy of honey in minimizing re-dressing
trauma and maintaining moist wound environment, crucial
for healing [42].
These assumptions get corroboration from present his-
topathological and immunohistochemical ﬁndings. The H
andEandVGstudiesdemonstratedthecharacteristic change
in epithelium and dermal collagen density and their distri-
bution towards normalcy during postintervention periods.
Whereas, immunohistochemical studies unveiled favorable
modulation in expression of prime epithelial molecules like
p63, E-cadherin and important members of dermal collagen
like I and III (Figure 3) in the same periods.
Interestingly, in preintervention samples, ﬂattened epi-
thelium (Figure 3(b))w i t hl e s sp 6 3 + cells demonstrated the
abnormal reductioncellularproliferationincontrast topost-
intervention periods with increased p63+ cells and normal
epithelial maturation features with the appearance of rete
pegs (Figures 3(c) and 3(d)). The analysis of membranous
expression of E-cadherin in postintervention biopsies (Fig-
ures3(g)and 3(h))in contrasttopredominantlycytoplasmic
expression in preintervention one (Tables 1 and 2)f u r t h e r
indicated the restoration of coherent cell-cell adhesion, a
good feature for healthy re-epithelialization [45–47]. In the
contextof such modulationinexpression ofCa+2-dependent
E-cadherin,theCa+2 inhoneymayhavesigniﬁcance[48–51].
The ﬁndings on collagen I and III (Figures 3(k), 3(l),
and 3(o), 3(p)) in postintervention biopsies revealed gradual
restoration of collagens towards normalcy (Figures 3(i) and
3(m)) in terms of their density distribution [21, 22]w h i c h
were corroborative with the VG ﬁndings and also with less
scarring. The Collagen I and III ratio analysis (Table 1)
supported the notion that under honey healing, the regener-
ated skin achieved almost thenormal ratio in respect to these
major ﬁbrillar molecular components [52].
Present approach allowed us to generate semiquanti-
tative data on molecular expression for better interpreta-
tion ofthe immunohistochemical observations. The adoptedEvidence-Based Complementary and Alternative Medicine 5
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Figure 3: Immunohistochemical photomicrographs (40x oil, a-p) of skin biopsies (normal and leg wound periphery): (a)–(d) depicted
expression of p63 in intact (a), before (b), after 15th days (c), and 22nd days (d) of topical intervention of honey: (e)–(h) demonstrated
E-cadherin expression in diﬀerent cellular layers of epithelium in normal (e) skin and in peripheral biopsies of before (f) and after said days
of interventions (g), (h); (i)–(p) depicted expression of Collagen I (i)–(l) and Collagen III (m)–(p) in normal skin (i), (m), preintervention
(j), (n) and in early (k), (o) and late (l), (p) periods of postintervention. The expression of p63 (b), E-cadherin (f), collagen I (j) and III
(n) in ﬂattened epithelium in preintervention stage andtheir changed expression statusin normaland postintervention periods-p63
+ nuclei
distribution (a), (c), and (d), increased E-cadherin expression (e), (g), and (h), altered Collagen I (i), (k), and (l) and Collagen III (m), (o),
and (p) density, orientation, and distribution.6 Evidence-Based Complementary and Alternative Medicine
Table 1: ANOVA in evaluating E-cadherin, Collagen I and III intensity diﬀerences within and between the study classes and assessment of
collagen ratios.
Molecule of interest Study groups
NP1 NP2 NP3 BP1 BP2 BP3 A15P1 A15P2 A15P3 A22P1 A22P2 A22P3
E-cadherin
Mean (Sd) 6.64
(0.99)
9.00
(1.04)
9.16
(0.94)
5.16
(1.18)
4.24
(1.45)
4.12
(1.99)
7.08
(1.35)
9.32
(1.14)
7.88
(1.13)
5.88
(1.20)
8.60
(1.47)
8.36
(1.29)
F value within study gr. 50.39∗ 3.263∗ 21.90∗ 32.29∗
F value between study
gr.
89.07∗
Collagen I
Mean (Sd) 4.48
(1.16)
4.84
(1.14)
4.44
(1.73)
9.68
(0.63)
9.36
(0.7)
7.84
(0.72)
8.76
(0.93)
7.64
(1.44)
6.68
(1.38)
4.68
(1.07)
5.04
(1.54)
4.84
(2.12)
F value within study gr. 0.64∗ 40.87∗ 16.85∗ 0.31∗
F value between study
gr.
173∗
Collagen
III
Mean (Sd) 4.44
(0.87)
4.44
(0.87)
2.16
(1.03)
6.88
(1.13)
5.68
(1.07)
4.60
(1.35)
6.16
(1.205)
4.92
(1.08)
4.41
(0.92)
4.48
(0.87)
4.28
(0.84)
2.31
(1.11)
F value within study gr. 50.57∗ 22.94∗ 39.10∗ 39.62∗
F value between study
gr.
34.40∗
Collagen ratio (I/III) 1.25 1.57 1.49 1.31
∗P value <.0001, N-Normal skin, B-Before intervention of honey, A15-15 days after intervention and A22-22 days after intervention.
Table 2: Relative intensity distribution of E-cadherin expression in stratum basilaris and stratum spinosum.
Sample
Stratum basilaris Stratum spinosum
Overall intensity
distribution
Expression intensity
according to cellular sites
Overall intensity
distribution
Expression intensity
according to cellular sites
Normal 8.40 ± 0.81 6.60 ±0.57 7.68 ±1.02 8.48 ± 0.51
Preintervention 3.96 ± 1.45 1.36 ±0.49 3.72 ±1.13 3.04 ± 0.89
15th day of
Postintervention 6.80 ± 1.00 2.88 ±0.88 6.26 ±0.91 5.56 ± 0.92
20th day of
postintervention 7.68 ± 0.80 6.00 ±0.76 7.36 ±1.11 7.84 ± 0.69
quantiﬁcation technique could diﬀerentiate the normal, pre-
and postintervention biopsies in respect to their remarkable
diﬀerences in molecular expression during progression of
healing under honey. Further precision could be achieved
in future studies by using ﬂuorescent confocal imaging with
spectral information and colour image processing.
From the above discussion, it may be opined that the im-
munohistochemical ﬁndings not only demonstrated impor-
tant molecular events in re-epithelialization and connective
tissue formation in LLW before and after honey dressing for
the ﬁrst time but also corroborated with the clinical and
histopathological ﬁndings to interpret the conversion of
nonhealing wound into healing one after such intervention.
Thus, these therapeutic impacts at the molecular levels that
is the increased p63+ cell and membranous expression of E-
cadherin as well as Collagen I and III deposition towards
normalcy in the regenerated skin of LLW convincingly
exhibited the molecular features to assess the wound healing
progression under honey dressing.
5.Conclusion
The honey with its diverse chemical constituents (organic
and inorganic) provide therapeutic support to nonhealing
lower limb wounds with minimum trauma during redress-
ing and debridement as well as in healing without hyper-
granulation and less scarring. Further, therapeutic potential
hasbeendemonstratedatmolecularlevelsthroughimmuno-
histochemical depiction of prime molecular expressions in
woundbiopsies.Thegradualincreaseinp63+ cellpopulation
and membranous expression of E-cadherin pointed out the
transformation of nonhealing wound into healing one and
achievement of collagen I and III ratio towards normalcyEvidence-Based Complementary and Alternative Medicine 7
in posttherapeutic periods indicated proper deposition of
collagens in the regenerated skin during heal-ing.
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